Showing results (101-110 of 115) with videos related to

Sort By:
Pageof 12
Journal of Experimental & Clinical Cancer Research : CR|September 10, 2004
Single-agent vinorelbine in pretreated breast cancer patients: comparison of two different schedulesE Terzoli, C Nisticò, A Fabi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 1, 1994
Oral doxifluridine in elderly patients with metastatic colorectal cancer: a multicenter phase II studyA Falcone, E Pfanner, S Ricci, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 11, 1991
Clinical spectrum of accidental hemlock poisoning: neurotoxic manifestations, rhabdomyolysis and acute tubular necrosisD Rizzi, C Basile, A Di Maggio, et al.
Biomed Research International|May 31, 2014
Activity and safety of bevacizumab plus fotemustine for recurrent malignant gliomasV Vaccaro, A Fabi, A Vidiri, et al.
Breast Cancer Research and Treatment|October 12, 1999
Breast cancer and timing of surgery during menstrual cycle: a 5-year analysis of 248 premenopausal womenM Milella, C Nisticò, V Ferraresi, et al.
Haematologica|September 1, 1995
Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liverP Mazza, R Giua, S De Marco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 8, 2001
A re-evaluation of carcinoembryonic antigen (CEA) as a serum marker for breast cancer: a prospective longitudinal studyF Guadagni, P Ferroni, S Carlini, et al.
British Journal of Cancer|June 1, 2006
Second- and third-generation aromatase inhibitors as first-line endocrine therapy in postmenopausal metastatic breast cancer patients: a pooled analysis of the randomised trialsG Ferretti, E Bria, D Giannarelli, et al.
Breast Cancer Research and Treatment|October 27, 2001
Serum tissue polypeptide specific antigen (TPS): a complementary tumor marker to CA 15-3 in the management of breast cancerR D'Alessandro, M Roselli, P Ferroni, et al.
Expert Review of Clinical Pharmacology|January 21, 2021
Radical metastasectomy followed by sorafenib versus observation in patients withclear cell renal cell carcinoma: extended follow -up of efficacy results from the randomized phase II RESORT trialA Mennitto, E Verzoni, F Cognetti, et al.
Pageof 12